Page last updated: 2024-12-06

sanfetrinem

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sanfetrinem: orally absorbed hexetil ester of GV-104326 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71452
CHEMBL ID316197
SCHEMBL ID75048
MeSH IDM0273517

Synonyms (20)

Synonym
CHEMBL316197
sanfetrinem
(1s,5s,8as,8br)-1-[(1r)-1-hydroxyethyl]-5-methoxy-2-oxo-5,6,7,8,8a,8b-hexahydro-1h-azeto[1,2-b]isoindole-4-carboxylic acid
156769-21-0
(1s-(1alpha(s*),5alpha,8aalpha,8balpha))-1,2,5,6,7,8,8a,8b-octahydro-1-(1-hydroxyethyl)-5-methoxy-2-oxoazeto(2,1-a)isoindole-4-carboxylic acid
unii-0s36458i44
azeto(2,1-a)isoindole-4-carboxylic acid, 1,2,5,6,7,8,8a,8b-octahydro-1-(1-hydroxyethyl)-5-methoxy-2-oxo-, (1s-(1alpha(s*),5alpha,8aalpha,8balpha))-
0s36458i44 ,
1,2,5,6,7,8,8a,8b-octahydro-1-(1-hydroxyethyl)-5-methoxy-2-oxoazeto(2,1-a)isoindole-4-carboxylic acid (1s-(1alpha(s*),5alpha,8aalpha,8balpha))-
sanfetrinem [inn:ban]
sanfetrinem [inn]
SCHEMBL75048
gtpl10856
gv104326
Q27237165
gv 104326
azeto[2,1-a]isoindole-4-carboxylic acid, 1,2,5,6,7,8,8a,8b-octahydro-1-[(1r)-1-hydroxyethyl]-5-methoxy-2-oxo-, monosodium salt, (1s,5s,8as,8br)-
(1s,5s,8as,8br)-1-[1(r)-hydroxyethyl]-5-methoxy-2-oxo-1,2,5,6,7,8,8a,8b-octahydroazeto[2,1-a]isoindole-4-carboxylic acid
gv 326
azeto[2,1-a]isoindole-4-carboxylic acid, 1,2,5,6,7,8,8a,8b-octahydro-1-[(1r)-1-hydroxyethyl]-5-methoxy-2-oxo-, (1s,5s,8as,8br)-

Research Excerpts

Overview

Sanfetrinem is a trinem beta-lactam which can be administered orally as a hexatil ester.

ExcerptReferenceRelevance
"Sanfetrinem is a trinem beta-lactam which can be administered orally as a hexatil ester. "( Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.
Babini, GS; Livermore, DM; Yuan, M, 1998
)
2.02

Bioavailability

ExcerptReferenceRelevance
" The oral bioavailability was 32% in rat and 15% in dog."( Sanfetrinem and sanfetrinem-cilexetil: disposition in rat and dog.
Bottacini, M; Grossi, P; Iavarone, L; Morandini, C; Pugnaghi, F, 1997
)
1.74
"Although prediction of the plasma profile of lipophilic drugs solely on the basis of in vitro data remains an ambitious target, this study shows that the plasma profile of a lipophilic drug can be predicted with appropriate in vitro dissolution data, provided that the absolute bioavailability of the drug is known and the drug has dissolution limited absorption."( Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration.
Dressman, JB; Nicolaides, E; Reppas, C; Symillides, M, 2001
)
0.31
"These results suggest that the morpholinoethyl esters of LK-157 and sanfetrinem could be further investigated to assess bioavailability in vivo."( Permeability of a novel beta-lactamase inhibitor LK-157 and its ester prodrugs across rat jejunum in vitro.
Iglicar, P; Legen, I; Prezelj, A; Selic, L; Vilfan, G, 2009
)
0.59

Dosage Studied

ExcerptRelevanceReference
") administration of the radiolabelled parent compound, and oral dosing of the hexetil ester prodrug, 14C-sanfetrinem-cilexetil."( Sanfetrinem and sanfetrinem-cilexetil: disposition in rat and dog.
Bottacini, M; Grossi, P; Iavarone, L; Morandini, C; Pugnaghi, F, 1997
)
1.95
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID438298Inhibition of penicillin-resistant Streptococcus pneumoniae 5204 PBP2X preincubated for 4 hrs before addition of substrate (R)-[2-(benzoylamino)propionylsulfanyl]acetic acid2009Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
AID438297Inhibition of penicillin-sensitive Streptococcus pneumoniae R6 PBP2X preincubated for 1 hr before addition of substrate (R)-[2-(benzoylamino)propionylsulfanyl]acetic acid2009Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's17 (65.38)18.2507
2000's9 (34.62)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.55 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.85%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]